Matthew T. Wiley

BTAI

Matthew T. Wiley serves as Chief Commercial Officer at BioXcel Therapeutics, Inc. (BTAI). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

4 trades

$6.6K

Net Position

Net Seller

$6.6K

Companies Traded

BTAI

Active Period

Mar 2024 – Sep 2024

4 total trades

Most Recent

Sell BTAI

Sep 17, 2024 · $3.4K

Matthew T. Wiley's Insider Trading at BioXcel Therapeutics, Inc. (BTAI)

Buys

0 · $0.00

Sells

4 · $6.6K

Total Shares Bought

Total Shares Sold

7,739

BTAI Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Sep 17, 2024	Sell	6,272	$0.55	$3.4K
Sep 15, 2024	Sell	215	$0.69	$148.52
Jun 15, 2024	Sell	244	$1.26	$308.10
Mar 15, 2024	Sell	1,008	$2.64	$2.7K

Related Insiders

Vimal Mehta

director, officer: CEO and President

BTAISell · May 22, 2026

Javier Rodriguez

officer: See Remarks

BTAISell · May 22, 2026

Richard I Steinhart

officer: Chief Financial Officer

BTAISell · May 22, 2026

Frank Yocca

officer: Chief Scientific Officer

BTAISell · May 22, 2026

Explore More Insider Trading Data

BTAI Insider Trading Activity

View all insider trades at BioXcel Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity